Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial

Shulman, M., Choo, T.-H., Ohrtman, K., Pavlicova, M., Rotrosen, J., & Nunes, E. V. (2025). Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial. Drug and Alcohol Dependence, 268, 112550. https://doi.org/10.1016/j.drugalcdep.2025.112550
Authors:
Matisyahu Shulman
Tse-Hwei Choo
Kaitlyn Ohrtman
Martina Pavlicova
John Rotrosen
Edward V Nunes
Affiliated Authors:
Matisyahu Shulman
Kaitlyn Ohrtman
Martina Pavlicova
Edward V Nunes
Columbia Affiliation:
Subjects:
Naltrexone (MeSH)
Opioid-Related Disorders (MeSH)
Buprenorphine (MeSH)
Narcotic Antagonists (MeSH)
Author Keywords:
opioid use disorder
cannabis use disorder
buprenorphine
naltrexone
timeline follow back
treatment effect
elink
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2025.112550
PMID:
39892089
DOI:
10.1016/j.drugalcdep.2025.112550
Journal:
Drug and Alcohol Dependence
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: